Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Historical Holders from Q4 2021 to Q3 2025

Symbol
PYXS on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
62,933,385
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
26,713,589
Holdings value
$59,287,871
% of all portfolios
0%
Number of holders
72
Number of buys
25
Number of sells
-45
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sullivan Lara 11.21% +9.1% $7,844,727 +$955,040 7,543,007 +14% Lara Sullivan, M.D. 31 Mar 2025
GordonMD Global Investments LP 6.2% $5,330,289 3,834,740 GordonMD Global Investments LP 14 Jul 2025
INTEGRATED CORE STRATEGIES (US) LLC 4% -26% $2,587,602 -$698,942 2,488,079 -21% Millennium Management LLC 31 Mar 2025
BlackRock, Inc. 1.5% -68% $2,192,635 -$5,718,934 926,805 -72% BlackRock, Inc. 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 1.3% -73% $1,497,185 -$4,985,888 818,134 -77% Millennium Management LLC 30 Sep 2025
Ridgeback Capital Investments L.P. 0.6% $373,600 359,231 Ridgeback Capital Investments L.P. 31 Dec 2024

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 26,713,589 $59,287,871 +$123,860 $2.22 72
2025 Q2 27,457,764 $30,197,446 -$2,879,012 $1.1 74
2025 Q1 30,249,732 $29,641,653 -$2,654,672 $0.9799 88
2024 Q4 31,554,509 $49,227,444 -$20,797,470 $1.56 97
2024 Q3 27,885,908 $103,378,553 -$998,440 $3.67 91
2024 Q2 28,117,599 $93,075,160 +$16,220,879 $3.31 78
2024 Q1 22,927,678 $97,671,130 +$61,948,310 $4.26 69
2023 Q4 8,795,542 $15,830,945 +$874,420 $1.8 50
2023 Q3 7,757,315 $15,436,473 -$3,354,663 $1.99 49
2023 Q2 9,605,170 $24,586,580 -$3,344,692 $2.56 46
2023 Q1 10,344,999 $41,482,052 -$20,570,227 $4.01 46
2022 Q4 19,762,209 $26,479,807 -$1,331,635 $1.34 31
2022 Q3 19,443,728 $38,301,000 -$1,468,358 $1.97 35
2022 Q2 20,034,321 $47,682,000 -$658,113 $2.38 37
2022 Q1 18,945,997 $76,067,000 -$5,559,229 $4.04 44
2021 Q4 18,338,628 $199,903,000 +$199,792,959 $10.97 51